LMT 25 (Lamictal ODT 25 mg)
Generic Name: lamotrigine
Pill imprint LMT 25 has been identified as Lamictal ODT 25 mg.
Lamictal ODT is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamictal ODT 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- lamotrigine
- Imprint:
- LMT 25
- Strength:
- 25 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0772
- Inactive Ingredients:
- crospovidone
mannitol
sucralose
ethylcellulose (100 mPa.s)
Note: Inactive ingredients may vary.
More about Lamictal ODT (lamotrigine)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 2 Reviews – Add your own review/rating
- Generic Availability
- Drug class: triazine anticonvulsants
Consumer resources
Professional resources
Other Formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
